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Parathyroid-Mediated Bone Loss
Sudhaker D. Rao, M D *

f d. Note - This overview was originally presented at the
International Symposium on Clinical Disorders of Bone
and Mineral Metabolism, May 9-13,1983. The following
list indicates the presentations given in this session at the
Symposium and the contents ofthe corresponding
chapter in the Proceedings of the Symposium published by
Excerpta Medica. The numbers in parentheses refer to
pages in this volume. Complete information about the
contents of the Proceedings can be found at the back of
this issue.

A m o n g the many causes of diminished skeletal mass,
parathyroid hormone (PTH)-mediated bone resorption
has been most widely studied experimentally, and agerelated osteoporosis is the least understood. Because of
histologic heterogeneity, it has been assumed that the
etiology of osteoporosis, either postmenopausal (Type I)
or senile (Type II), is multifactoral (Riggs, et al, pp. 337 ff.).
This session examined the possible contribution of PTHmediated bone loss to the pathogenesis of osteoporosis.
Raisz (pp. 196 ff.) reviewed the actions of PTH on bone
that might cause bone loss. Bone resorption is stimulated
acutely, with an increase in both the activity and the
number of osteoclasts. Since these cells lack PTH receptors, the effect of the hormone may be mediated by
action on the bone lining cells (Parfitt, et al, pp. 328 ff.).
These and other cells of osteoblast lineage possess PTH
receptors, and PTH acutely inhibits collagen synthesis.
The longer term effect of increased bone formation is
probably brought about by the coupling mechanism
(Mohan, et al, pp. 173 ff.). Whether the summation of
these short- and long-term effects is catabolic or anabolic
may depend on the intake and absorption of dietary
calcium and on the plasma phosphate level.

Estimation of trabecular bone resorption by histomorphometry: Evidence for a prolonged reversal phase with
normal resorption in post menopausal osteoporosis and
coupled increased resorption in primary hyperparathyroidism. R. Baron, S. Magee, A. Silverglate, A. Broadhus,
and R. Long (191)
Mechanisms of parathyroid hormone mediated bone
loss. L.G. Raisz (196)
PTH mediated bone loss in primary and secondary
hyperparathyroidism. M . Kleerekoper, A.R. Villanueva,
C.H.E. Mathews, D.S. Rao, B. Pumo, and A . M . Parfitt (200)
V/(am;n D deficiency and hip fractures: Cause or coincidence? P. Lips, M.J.M. Jongen, F.C. van Giunkel, W.J.F.
van der Vijgh, R. Bouillon, W.H.L. Hackeng, and J.C.
Netelenbos (204)

Baron (pp. 191 ff.) reviewed the histologic assessment of
bone resorption. Osteoclasts occupy only a small fraction
of the total crenated (Howship's) lacunar surface. The
remainder are covered by various kinds of mononuclear
cells that appear in the time interval between the end of
resorption and the beginning of formation and identify
the so-called reversal surface. In hyperparathyroidism
and other states of increased bone turnover, the increase
in total resorption surface reflects an increase in osteoclast surface. O n the other hand, in postmenopausal and
other types of osteoporosis, the increase in total resorption surface reflects only an increase in reversal surface.
Accordingly, increased total resorption surface is not a

Osteoclastic resorption of osteoid in secondary hyperparathyroidism. M i n g Cai Q i u , C. Mathews, and A . M .
Parfitt (209)
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valid index of increased resorption rate in osteoporosis.
Q i u (pp. 209 ff.) reviewed another facet of the histologic
assessment of bone resorption and found that osteoclasts
normally avoid osteoid and resorb only unmineralized
bone. However, osteoclastic resorption of osteoid may
occur with the stimulus of severe hyperparathyroidism.
Kleerekoper (pp. 200 ff.) demonstrated that chronic
hyperparathyroidism, whether primary or secondary,
accelerates age-related loss of cortical bone. Loss of trabecular bone, observed in only a small subset of patients
with primary hyperparathyroidism, was more substantial
in patients with secondary hyperparathyroidism due to
gastrointestinal malabsorption of calcium. However,
even in these patients, the relative deficit was significantly greater for cortical than for trabecular bone. This
conclusion differs f r o m that o f o t h e r investigators, partly
because of different interpretation of measurements by
single p h o t o n a b s o r p t i o m e t r y at the distal radius.
Although this measurement is generally believed to
indicate the loss of trabecular bone, our studies indicate
that trabecular bone atthis site is metabolically inert and
that, as at the proximal site, losses are due predominantly
to cortical thinning. None of the studied patients had
sustained a fracture, but in another session Rao d e m o n -

strated a significant increase in fracture risk for patients
with secondary hyperparathyroidism even without osteomalacia (Rao, et al, pp. 224 ff.).
Lips (pp. 204 ff.) examined the relationship between subclinical vitamin D deficiency and hip fractures in elderly
patients. Iliac histomorphometry o f t h e patients with hip
fracture was divided into three groups: increased t u r n over (increased resorption and formation); impaired
coupling (increased resorption and normal formation);
and low turnover (depression of both resorption and
formation). This analysis was based on static measurements not on kinetic studies with tetracycline labeling.
In the high turnover group, the plasma calcidiol level
was low and cortical thickness in the ilium was significantly reduced. None o f t h e patients had osteomalacia as
defined elsewhere (Rao, et al, pp. 224 ff.). The data were
consistent with the view that the early osseous effects of
vitamin D deficiency are mainly those of secondary
hyperparathyroidism, leading to accelerated loss of cortical bone. In general, PTH-mediated bone loss probably
makes little contribution to postmenopausal osteoporosis (Type I) with vertebral compression fractures, but may
significantly contribute to senile osteoporosis (Type II)
leading to hip fractures.
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